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Hexokinase (HK), the rate-limiting enzyme in glycolysis,
controls cell survival by promoting metabolism and/or
inhibiting apoptosis. Since HK isoforms I and II have
mitochondrial targeting sequences, we attempted to
separate the protective effects of HK on cell metabolism from
those on apoptosis. We exposed renal epithelial cells to
metabolic stress causing ATP depletion in the absence of
glucose and found that this activated glycogen synthase
kinase 3b (GSK3b) and Bax caused mitochondrial membrane
injury and apoptosis. ATP depletion led to a progressive HK II
dissociation from mitochondria, released mitochondrial
apoptosis inducing factor and cytochrome c into the cytosol,
activated caspase-3, and reduced cell survival. Compared
with control, adenoviral-mediated HK I or II overexpression
improved cell survival following stress, but did not prevent
GSK3b or Bax activation, improve ATP content, or reduce
mitochondrial fragmentation. HK I or HK II overexpression
increased mitochondria-associated isoform-specific HK
content, and decreased mitochondrial membrane injury and
apoptosis after stress. In vivo, HK II localized exclusively to the
proximal tubule. Ischemia reduced total renal HK II content
and dissociated HK II from proximal tubule mitochondria.
In cells overexpressing HK II, Bax and HK II did not interact
before or after stress. While the mechanism by which HK
antagonizes Bax-mediated apoptosis is unresolved by these
studies, one possible scenario is that the two proteins
compete for a common binding site on the outer
mitochondrial membrane.
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Hexokinase (HK) converts glucose to glucose-6-phosphate,
the rate-limiting step in glycolysis. As the kidney contains
abundant amounts of HK, it has been assumed that its
primary role is to promote cell metabolism.1 However,
two HK isoforms, HK I and II have mitochondrial amino-
terminal targeting sequences that control ‘on’ and ‘off ’
HK shuttling at the outer mitochondrial membrane,2,3 a
key intracellular site that regulates aerobic metabolism
and apoptosis. Although the isoform-specific renal distri-
bution of HK I and II is unknown, total HK content is greater
in the medulla than in the cortex.4,5 Interestingly, in cancer
cell lines, including renal cell carcinoma, abundant levels
of HK I or II (ref. 6, 7) confer marked resistance to chemo-
therapy or other pro-apoptotic stimuli including ultraviolet
irradiation and oxidative stress.8 In these cancer cells,
protection by HK has been primarily attributed to its
benefits on cell metabolism.6,8
Recent evidence suggests that HK directly regulates
apoptosis. Specifically, HK appears to interfere with members
of the BCL2 protein family that mediate mitochondrial
membrane injury, a hallmark of apoptotic cell death.9,10
Although the binding site at the outer mitochondrial
membrane is presently debated (see Discussion11,12), it has
been suggested that mitochondrial-associated HK affords
protection against apoptosis caused by members of the BCL2
protein family, whereas dissociated HK might not.9,13,14 Of
the BCL2 proteins, pro-apoptotic Bax is an attractive target
for HK in renal epithelial cells, as metabolic stress activates
Bax, resulting in the exposure of the Bax carboxy-terminal
6A7 epitope,15 oligomerization16,17 and translocation to
mitochondria.17 Furthermore, Bax is rapidly activated by
renal ischemia in vivo.18 Bax activation and translocation are
partly mediated by Akt (protein kinase B) and glycogen
synthase kinase 3-b (GSK3b), potent kinases that phosphor-
ylate serine and either activate or inactivate Bax.19 As GSK3b
is activated in renal epithelial cells subjected to metabolic
stress18 or renal ischemia in vivo,18 we hypothesized
that mitochondria-bound HK ameliorates ‘Bax attack’ by
either inhibiting GSK3b activation, limiting Bax activation,
interacting with Bax or competing for Bax binding at the
outer mitochondrial membrane. Also, whether HK isoforms
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regulate renal epithelial cell survival by promoting metabo-
lism or inhibiting apoptosis is not known.
In the present study, renal epithelial cells were exposed to
metabolic stress in the absence of glucose, an ideal model for
separating the effects of HK on cell metabolism from its anti-
apoptotic effects at the level of the outer mitochondrial
membrane. We report that metabolic stress causes progressive
mitochondrial HK II displacement and a fall in total cellular
HK II content concomitant with GSK3b and Bax activation,
mitochondrial membrane permeabilization and cell death.
Renal ischemia in vivo also results in mitochondrial HK II
dissociation and a decrement in total HK content. In cultured
cells, enhancing HK I or II expression, the major renal HK
isoforms, decreases mitochondrial Bax accumulation and
improves cell survival without inhibiting GSK3b or Bax
activation or altering total cell ATP content after stress. HK II
is a relevant isoform, as it localizes to the proximal tubule, a
major site for ischemic injury. This study supports the
hypothesis that HK decreases apoptosis after metabolic stress
by antagonizing ‘Bax attack’ of the outer mitochondrial
membrane.
RESULTS
Effect of metabolic stress on HK II distribution in vitro and
in vivo
In intact control cells examined by immunofluorescence
microscopy at baseline, HK II co-localizes with Cox IV, a
mitochondrial marker (Figure 1, left panel). After 60 min of
ATP depletion followed by 15 min recovery, dramatic HK II
re-distribution away from mitochondria is observed (right
panel). Given the relatively large volume of cytosol, this
approach could not accurately assess HK II content in this
compartment. Therefore, to determine whether the loss of
mitochondrial-associated HK II is due to HK II degradation
and/or re-distribution, both total and cytosolic levels of HK
II after metabolic stress were assessed by immunoblot
analysis in cell lysates and digitonin-permeabilized cells,
respectively (Figure 2). Compared with baseline, total HK II
content progressively decreased after ATP depletion and
15 min recovery (top panel), suggesting that metabolic stress
promotes HK II degradation. Concomitant with the decrease
in total HK II, a transient increase in ‘cytosolic’ HK II was
detected after ATP depletion (middle panel).
In perfusion-fixed renal tissue, HK II localizes almost
exclusively to the proximal tubule (Figure 3a). A sharp
demarcation in HK staining is evident at the corticomedul-
lary junction (upper panels). HK II is abundant in the cortex
(middle panels) but is virtually absent in distal tubules
(lower panels). As observed in renal cells in culture
at baseline, HK II extensively co-localized with mitochondrial
specific F1F0-ATPase in proximal tubular cells in vivo
(Figure 3b, upper right panel and inset). HK II staining
was also prominent in the proximal tubule brush border
(upper middle panel, white arrow). After ischemia, however,
overall intracellular HK II staining intensity was markedly
reduced as compared with baseline (upper versus lower
middle panels) and minimal mitochondrial HK II was
detected (lower right panel and inset). Interestingly, brush
border HK II staining was no longer visible although
abundant HK II was detected in the lumens of post-ischemic
proximal tubules (lower right panel, solid arrow). Compared
with baseline, ischemia caused marked loss of immunor-
eactive renal HK II content (Figure 4). In fact, densitometric
analysis revealed a 40% decrement in renal HK II content
after ischemia (Po0.05; n¼ 4; Figure 4b). In contrast, sham
ischemia did not significantly alter HK II content (data not
shown; P40.05). These results show that renal ischemia
in vivo causes marked HK-II re-distribution and intracellular loss
in a manner that parallels the effects of ATP depletion in vitro.
Effect of HK I or II overexpression on mitochondrial HK
content, mitochondrial membrane injury, caspase 3
activation, and cell survival after metabolic stress
Compared with empty vector, proximal tubule cells exposed
to adenovirus expressing full-length human HK I exhibited
increased mitochondrial-associated HK I expression without
altering that of HK II (Figure 5a, upper panel). Similarly,
overexpression of HK II did not alter organelle-associated
HK I content (middle panel). However, increased HK I or
HK II expression reduced mitochondrial membrane injury
after metabolic stress. Compared with control (empty vector),
cells overexpressing either HK I (Figure 5b, upper panels) or
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Figure 1 |Metabolic stress causes hexokinase (HK) II to
dissociate from mitochondria. HK II (red) and Cox IV (green), an
outer mitochondrial membrane protein, by immunofluorescence
at baseline and following 15min recovery from 60min ATP
depletion.
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Figure 2 | Effect of metabolic stress on cell hexokinase (HK) II
distribution. Total (upper panel) and cytosolic (middle panel) HK
II content assessed by immunoblot analysis in cell lysates and in
soluble extracts of digitonin-treated cells, respectively, at baseline
(Base), after 60min ATP depletion (ATP60), and 15min recovery
(Rec15); b-tubulin serves as a loading control (lower panel).
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HK II (lower panels) released less apoptosis-inducing factor
(AIF) from mitochondria after stress (Figure 5b; lanes 5 and
6 versus 2 and 3 of top panel in each pair). In control, pro-
caspase 3, the inactive precursor of caspase 3, progressively
decreased (Figure 5c, top panel, first 3 lanes), confirming that
metabolic stress induces enzyme activation in renal epithelial
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Figure 3 |Effect of renal ischemia in vivo on mitochondrial-associated hexokinase (HK) II. (a) Phase contrast, HK II immunofluorescence (red),
and merged images of the corticomedullary (CM) junction (upper panels); renal cortex (middle panels) and medulla (lower panels) of normal
murine renal tissue. HK II localizes to the proximal tubule. (b) HK II (red) partially co-localizes with mitochondrial F1F0-ATPase (green) at baseline as
indicated by orange-yellow staining (right upper panel); HK II dissociates from mitochondria after 40min renal artery occlusion as shown by
separation of the red and green signals (right lower panels); original magnification X630. Arrow indicates brush border with prominent HK II
staining. Solid arrow shows HK II in the lumen of a proximal tubule. Inset shows mitochondrial staining at higher magnification to show differences
in mitochondrial HK II before versus after renal ischemia. These images are representative of at least three separate studies.
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cells.1 Unlike control, HK II overexpression maintains caspase 3
predominantly in its inactive form despite ATP depletion
(top panel—second 3 lanes), indicating that HK limits outer
membrane injury. Although only 64.5þ 1.4% of control cells
survived after stress, survival reached 84.8þ 8.1% of HK I
and 92.8þ 2.4% of HK II overexpressing cells (Figure 5d;
Po0.05 versus empty vector; n¼ 4). Exposure of cells to
adenovirus containing either the HK I or II isoform increased
total cell HK I or HK II content, respectively (Figure 5d,
inset), without altering the expression level of the other
isoform (not shown).
Effect of HK II expression on ATP content before and after
metabolic stress
Exposure to two metabolic inhibitors in the absence of
medium glucose resulted in a rapid fall in total ATP content
to B10% of the baseline value (Figure 6) as previously
reported by our laboratory.20 During recovery, total ATP
content progressively increased after removing both inhibi-
tors and adding glucose to the medium. No significant
differences in total ATP content between control and HK II
overexpressing cells were evident before, during, or after
metabolic stress, suggesting that increasing HK II content in
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Figure 4 |Renal ischemia in vivo alters hexokinase (HK) II. (a) Effect of 40min unilateral renal artery occlusion on HK II content in renal
homogenates (‘R’ or right kidney) compared with baseline (‘L’ or left kidney) in four representative animals; mitochondrial F1F0-ATPase
serves as loading control. (b) Densitometric analysis of HK II in unilateral sham ischemia (n¼ 6) versus unilateral renal ischemia; n¼ 6;
Po0.05 versus baseline or sham. Ischem, ischemia.
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Figure 5 | Effect of hexokinase (HK) I or II overexpression on mitochondrial-associated HK, organelle injury, caspase 3 activation,
and cell survival after stress. (a) HK I and HK II content in isolated mitochondria harvested from cells that express either HK I, HK II,
or empty vector (EV). (b) Mitochondrial membrane injury assessed by leakage of apoptosis-inducing factor (AIF) into the cytosol of
digitonin-permeabilized cells (upper panel) at baseline (base), after 60min ATP depletion (ATP60), and following 15min recovery (Rec15)
in empty vector versus HK I (a) or II (c) overexpressing cells (HK I or II AdV); b-tubulin loading control (lower panel). (c) Content of
pro-caspase 3, the inactive form of the apoptotic enzyme at baseline (base), after 60min ATP depletion (ATP60), and following 15min
recovery (Rec15) in HK II overexpressing versus empty vector cells. (d) Survival assessed by the MTT assay in empty vector (EV) versus
HK II overexpressing cells (HK II AdV) after 2 h ATP depletion followed by 6 h recovery (Rec6h); immunoblot analysis confirming HK II
overexpression without altering HK I content (inset).
1210 Kidney International (2011) 79, 1207–1216
or ig ina l a r t i c l e JM Gall et al.: Hexokinase inhibits mitochondrial injury
the presence of metabolic inhibitors does not alter total
adenine nucleotide content.
Effect of HK II overexpression on mitochondrial morphology
At baseline, mitochondria appear elongated or ‘filamentous’
both in cells incubated with adenovirus containing either
empty vector or HK II (Figure 7a and b). ATP depletion
caused mitochondria to become punctate (Figure 7c and d).
HK II expression failed to prevent this change, suggesting
that cytoprotection does not operate at the level of organelle
dynamics.
Effect of HK II on GSK3b and Bax activation
To measure the potential effect of HK II expression on
GSK3b activation during metabolic stress, p-ser9 GSK3b, the
inactive form of this kinase, was serially measured in lysates
from control and HK II overexpressing cells before and after
metabolic stress (Figure 8). In control cells, GSK3b is
activated (that is, p-ser9 GSK3b content markedly decreases)
during ATP depletion and is then rapidly inactivated (that is,
p-ser9 GSK3b content increases) during recovery (top panel;
HK II minus). The pattern of GSK3b activation and
inactivation is virtually identical in HK II overexpressing
cells (top panel; HK II plus), showing that HK II acts
downstream of GSK3b activation.
To confirm the pathogenic role of Bax in our model, Bax
content was reduced with a specific small interfering
RNA, resulting in a 50–70% decrease in immunoreactive
Bax content (Figure 9a; top panel—lane 3 versus 1). In
contrast, non-specific RNA did not alter Bax content (lane 2).
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Figure 6 | Effect of hexokinase (HK) II overexpression on cell
ATP content after metabolic stress. Luciferase assay
measurements of total ATP content at baseline (base), after
60min ATP depletion (ATP depl), and after 5–120min recovery
in cells treated with either empty vector (EV) or HK II adenovirus
(HK II). Data are expressed as mean±s.e.; n¼ 6.
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Figure 7 | Effect of hexokinase (HK) II overexpression on
mitochondrial morphology. Morphology of mitochondria
stained with Mitotracker Green FM at baseline (a, b) or after
30min ATP depletion (c, d) in renal cells infected with either
control AdV (‘empty vector’) or HK II (‘HK II AdV’).
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Figure 8 | Effect of hexokinase (HK) II overexpression on
glycogen synthase kinase 3b (GSK3b) activation after
metabolic stress. Inactive (p-ser9) GSK3b content in cell lysates
by immunoblot analysis at baseline, after 60min ATP depletion
(ATP depl), and following 15, 30, and 60min recovery in cells
treated with either empty vector () or HK II adenovirus (þ ).
Total GSK3b loading control (lower panel).
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Figure 9 |Bax knockdown prevents mitochondrial leak of
pro-apoptotic effector proteins after metabolic stress. (a) Total
Bax content (upper panel) in control (Ctl) and cells treated with
either non-specific (NS) or Bax-specific (Bax) small interfering RNA
(siRNA) by immunoblot; b-actin loading control (lower panel).
(b) Apoptosis-inducing factor (upper panel) and cytochrome c
(Cyto c, middle panel) measured by immunoblot in the
digitonin-permeabilized Ctl, or cells exposed to NS or Bax siRNA
following 60min ATP depletion; b-actin loading control (lower panel).
Kidney International (2011) 79, 1207–1216 1211
JM Gall et al.: Hexokinase inhibits mitochondrial injury o r ig ina l a r t i c l e
In ATP-depleted cells, Bax knockdown markedly decreased
the release of both AIF (Figure 9b, top panel—lane 4 versus
lanes 2 and 3) and cytochrome c (middle panel—lane 4
versus lanes 2 and 3), confirming that Bax contributes to
organelle injury after metabolic stress. To determine whether
HK II regulates Bax activation, cell lysates were probed for
the 6A7 epitope, a region exposed only after Bax activation.15
The steady state content of active Bax increased to a similar
degree after ATP depletion and recovery in both control
(Figure 10, top panel—lanes 1–3) and HK II overexpressing
(top panel—lanes 4–6) cells, showing that HK II does not
prevent cell death by inhibiting Bax activation. To the
contrary, these results suggest that HK II limits active Bax-
mediated injury at the level of the outer mitochondrial
membrane.
Effect of metabolic stress on HK II–Bax interaction
To evaluate a potential mechanism of HK-mediated Bax
antagonism and cytoprotection, interaction between HK II
and Bax was examined in isolated renal epithelial cells before
and after ATP depletion. Although total Bax was readily
immunoprecipitated at baseline and after stress, no HK II
could be detected before or after stress despite HK II
overexpression (data not shown).
HK II prevents mitochondrial Bax accumulation during
metabolic stress
Mitochondrial Bax translocation and accumulation are
required to cause membrane injury and the release of pro-
apoptotic mediators. During recovery from ATP depletion
(Figure 11), HK II content decreased (upper panel) whereas
Bax content increased in control mitochondria (middle
panel). Compared with control, selective HK II expression
increased mitochondrial HK II content and markedly
reduced Bax accumulation content. Interestingly, the residual
amount of mitochondrial-associated HK II after stress in HK
II-overexpressing cells was comparable to that noted in
control at baseline (lane 3 versus lane 2). These results
suggest that HK II expression inhibits mitochondrial Bax
translocation and/or accumulation and is important for
preventing Bax-mediated organelle injury.
DISCUSSION
The present study shows that HK is a key regulator of
susceptibility to Bax-mediated mitochondrial membrane
permeabilization in renal epithelial cells. HK II is abundant
only in the proximal tubules, indicating for the first time that
this isoform is relevant to proximal tubule injury. After ATP
depletion in vitro (Figure 1), HK II is displaced from
mitochondria, cytosolic HK II content transiently increases,
and total HK II content markedly falls (Figure 2). Ischemia/
reperfusion in vivo causes similar displacement of mitochon-
drial HK II (Figure 3b) and a decrement in overall
intracellular HK II content (Figure 4a and b). The later
could be due to HK II degradation and/or to loss of HK to
the extracellular milieu. In a contemporaneous manner,
mitochondrial HK II content decreases (that is, 15 min
recovery after ATP depletion) and both GSK3b and Bax are
activated (Figure 8 and 10). Once activated, Bax accumulates
in mitochondria (Figure 11), caspase-dependent and inde-
pendent mediators (cytochrome c and AIF, respectively) are
released (Figure 5b and 9b), pro-caspase 3 is consumed
(Figure 5c), and cell death follows (Figure 5d). Although
other BCL2 proteins (including Bcl2, BclXL, and Bak and Bid)
also mediate apoptosis, Bax is critical in our model, as RNA
interference-mediated Bax knockdown is sufficient to
markedly reduce both mitochondrial AIF and cytochrome c
leakage (Figure 9b). The time course of these events is
consistent with previous reports in which apoptotic signaling
occurs within minutes of recovery from metabolic
stress.15,18,21 Specifically, Akt inactivation combined with
GSK3b activation lead to site-specific serine phosphorylation
that promotes Bax activation and cell death.14,18,19,22
Furthermore, activated GSK3b promotes mitochondrial HK
II displacement and apoptosis,14 whereas GSK3b inhibition
prevents HK II displacement and suppresses apoptosis.23
Once displaced, HK II is susceptible to ubiquitination and
proteasomal degradation,24 likely contributing to the rapid
Empty vector HK II AdV
Active
Bax
654321
Base BaseATP60 ATP60Rec15 Rec15
β-Actin
Figure 10 | Effect of hexokinase (HK) II overexpression on
stress-induced Bax activation. Active Bax (upper panel)
detected by immunoblot with an anti-6A7 epitope-specific
antibody in cells exposed to either empty vector or HK II
adenovirus (HK II AdV) at baseline (base), after 60min ATP
depletion (ATP60) and 15min recovery (Rec15); b-actin loading
control (lower panel).
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Figure 11 | Effect of hexokinase (HK) II overexpression on
mitochondrial HK II and Bax content. HK II (upper panel) and
total Bax (middle panel) assessed in isolated mitochondria
harvested from cells exposed to empty vector () or HK II (þ )
containing adenovirus at baseline and 15min recovery following
ATP depletion (Rec15). Voltage-dependent anion channel (VDAC),
an outer mitochondrial membrane protein, serves as loading
control (lower panel).
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loss of total cell HK II after ATP depletion (Figure 2) or renal
ischemia (Figure 4).
In our study, loss of mitochondrial HK II is clearly
associated with mitochondrial Bax accumulation (Figure 11),
AIF release (Figure 5b), caspase 3 activation (Figure 5c), and
cell death (Figure 5d). HK II overexpression increased
mitochondrial HK II content and reduced each of these
apoptotic parameters without altering HK I content (and vice
versa). Expression of either HK I or II, the two isoforms with
a mitochondrial targeting sequence, is sufficient to prevent
ATP depletion-induced mitochondrial injury (Figure 5b).
After ATP depletion, HK II overexpression was equivalent
(but did not exceed) to the level of mitochondrial-associated
HK II detected in control cells at baseline (Figure 11; lane 3
versus 2). This shows that maintaining mitochondrial-
associated HK II within the physiological range is sufficient
to inhibit Bax accumulation during stress (Figure 11), an
important cause of mitochondrial membrane permeabiliza-
tion in renal15,17 (Figure 9) and non-renal cells.14 Although it
is conceivable that HK II decreases susceptibility of the outer
membrane to ‘Bax attack’ by regulating mitochondrial
dynamics during stress,25 HK II overexpression failed to
prevent the dramatic shift from filamentous to punctate
mitochondria (Figure 7). This observation is consistent with
the absence of any effect on HK II overexpression on net ATP
content (Figure 6), as intact mitochondria and HK are both
prerequisites for metabolic coupling between the two. In
addition, neither HK I or HK II overexpression altered the
mitochondrial content of the other isoform (Figure 5a). This
observation excludes the possibility that HK I or II protects
mitochondria by reciprocally increasing organelle binding of
the other isoform. Furthermore, HK II failed to inhibit either
stress-induced GSK3b (Figure 8) or Bax activation (Figure 10)
and does not interact with Bax (data not shown). These
findings indicate that HK II does not normally saturate the
outer mitochondrial membrane and potentially interferes
with membrane attack by competing with active Bax for
binding at its target site(s).26,27 Although truncated HK I and
II mutants that lack mitochondrial targeting partially protect
cardiac myocytes against oxidant stress,28 this cell type and
the model of injury differ from the present study. Admittedly,
the kinetics of mitochondrial HK binding is complex and
may include both regulated and unregulated components for
each HK isoform. The physical basis and functional im-
portance of individual subsets of bound HK are incompletely
understood2,11 and are not addressed in the present work.
How mitochondrial HK II antagonizes ‘Bax attack’ is
presently debated. However, it is clear that the loss of
mitochondrial-bound HK promotes apoptosis.11,14 Recently,
Chiara et al.29 confirmed that mitochondrial HK inhibits
apoptosis. These investigators used an HK II amino-terminal
peptide to release mitochondrial HK II, resulting in dose-
dependent cell death. The present study is consistent with
this previous report by showing that displacement of HK
from mitochondria promotes cytochrome c release and
apoptosis, whereas increasing mitochondrial-associated HK
I or II limits mitochondrial membrane injury and enhances
renal cell survival. Loss of mitochondrial HK could expose
putative outer mitochondrial membrane sites for attack by
Bax or alter binding kinetics for targets such as the voltage-
dependent anion channel (VDAC).2,3,13,26,30–34 In either
scenario, Bax interaction with VDAC (or another proximate
site) appears to open a membrane pore to induce apoptosis,
whereas maneuvers that increased HK II–VDAC interaction
decreases outer membrane susceptibility to Bax.35,36
Although HK II failed to inhibit the activation of GSK3b
(Figure 8), a key Bax regulatory enzyme,18 or limit Bax
activation after stress (Figure 10), it is possible that HK binds
and sequesters active Bax in the cytosol. However, no
interaction between active Bax and HK II was detected by
immunoprecipitation even in stressed renal cells that over-
express HK II, suggesting that this is unlikely to be its
primary mode of cytoprotection. The multimodal effects of
HK II on cell survival are illustrated by the fact that HK
protects cells with double Bax and Bak knockout against
apoptogenic stress.37 As well, HK has two major binding
sites: phosphohexose-dissociable (type A) and non-dissoci-
able (type B). Therefore, relatively small changes in HK
expression, compartmentalization, and/or binding in our
model, mediated by a distinct subset of HK-binding sites,
could exert major effects on cytoprotection.38
Whether or not VDAC is the only HK-binding site is
controversial. On one hand, VDAC-1 overexpression causes
apoptosis in diverse cell lines,26,31,39–41 whereas VDAC-1
knockdown suppresses apoptosis,41,42 suggesting that this site
has a critical role in outer mitochondrial membrane
permeabilization. On the other hand, ionomycin, stauros-
porine, H2O2, and tumor necrosis factor-a induce mitochon-
drial membrane permeabilization and apoptosis even in
cells with complete VDAC-1 and -3 knockout and RNA
interference-mediated partial knockdown of VDAC-2
(ref. 12) Similarly, an HK-related peptide that displaces
endogenous HK caused apoptosis in cells that lacked both
VDAC-1 and -3 (ref. 29) In these studies in which VDAC-1 and
-3 were absent, some VDAC-2 remained as the complete
absence of VDAC-2 is lethal.12,29 Unfortunately in these reports,
the amount of mitochondrial HK (perhaps more relevant than
total HK content) was not assessed. This may be an important
omission, as HK could bind multiple mitochondrial target
proteins in a hierarchical fashion (for example, VDAC-1, -2, -3)
or bind to other mitochondrial proteins present on the outer
membrane that interact with Bax. For example, Bax appears
to bind TOM22, a component of the translocase of the outer
mitochondrial membrane,43–45 an alternative HK II binding
site that has not been investigated.
Despite this controversy regarding its binding site, the
present study shows that mitochondrial bound HK II exerts
anti-apoptotic effects that are potentially independent of its
effect on ATP content or organelle morphology either during
or after cell injury. Our results differ from those reported in
some cancer cell lines in which the metabolic role of HK was
believed to afford cytoprotection.7,8 In these cancer cells,
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abundant HK resulted in higher levels of ATP, glucose-6-
phosphate, and lactic acid than that found in non-cancer
cells.6–8,46 In renal epithelial cells, a single study suggests that
endogenous and exogenous HK reduces oxidant injury via an
ATP-dependent mechanism.1 Although ATP content is
unchanged in HK overexpressing cell in the presence of
metabolic inhibitors, we cannot exclude the possibility that
ATP flux or other pathways, including the generation of
reactive oxygen species or VDAC phosphorylation, are altered
and contribute to HK-mediated protection. Others have
shown that HK mutants with defective mitochondrial
binding capacity inhibited oxidant-induced cell injury,
confirming that HK also has non-mitochondrial protective
effects.28 Additionally, HK II could afford cytoprotection by
altering proteolysis and/or autophagy. The present study
does suggest that either directly or indirectly, HK alters
mitochondrial susceptibility to Bax-mediated membrane
injury downstream of either GSK3b or Bax activation (Figure
8 and 10). As mitochondrial HK II binding is not normally
saturated and is further reduced by stress (Figure 11), we
suggest that mitochondrial HK is a potential target for
preventing organelle injury and for sustaining cellular
viability after an apoptogenic insult.
MATERIALS AND METHODS
Cell culture
Opossum kidney proximal tubule cells were cultured in Dulbecco’s
modified Eagles medium (DMEM; Mediatech, Manassas, VA; 4.5 g/l
of glucose, 584 mg/l L-glutamine, without pyruvate) supplemented
with 1% penicillin/streptomycin (Mediatech) and 10% fetal bovine
serum (Equitech-Bio, Kerrville, TX) at 371C in 5% CO2.
Metabolic stress
ATP depletion was initiated by exposing confluent cells to glucose-free
DMEM (Invitrogen, Carlsbad, CA; 584 mg/l L-glutamine without
pyruvate) containing sodium cyanide (5 mmol/l) and 2-deoxy-D-
glucose (5 mmol/l), a competitive glucose inhibitor, as previously
described by our laboratory.15 Cells were washed three times with
phosphate-buffered saline (PBS) and incubated with the above ATP
depletion media for 60–120 min at 371C in the presence of 5% CO2.
Recovery was initiated by washing twice with PBS followed by
incubation in standard DMEM containing 4.5 g/l glucose but without
metabolic inhibitors or serum. This insult consistently causes cell
death by apoptosis using established biochemical and morphological
criteria21,47 and is associated witho5% plasma membrane injury, an
important hallmark of cellular necrosis.20
Renal ischemia and reperfusion
Ischemia reperfusion studies were performed using 6-week-old mice
weighing 20–22 gm under standardized conditions as recently
described.18 After intraperitoneal injection of tribromoethanol
(250 mg per kg body weight), both kidneys were exposed by a
midline incision. For HK II degradation studies, the left renal
pedicle was ligated and the kidney removed to serve as ‘baseline’. An
occlusive non-traumatic microaneurysm clamp was placed on the
right renal pedicle for 40 min. After clamp removal, restoration of
blood flow was visually confirmed for 1 min and the right kidney
was harvested after 3 h reperfusion. For renal histological studies,
ischemia/reperfusion was performed on both kidneys using two
clamps. Sham-operated mice received identical surgical procedures
with the exception that clamps were not applied. Procedures were
performed under conditions in accordance with guidelines set by the
National Institutes of Health and the Institutional Animal Care and
Use Committee of Boston University.
Immunoblot analysis
Lysates were harvested from cells in RIPA buffer with EDTA (Boston
BioProducts, Worcester, MA) containing a protease inhibitor
cocktail (Set I; Calbiochem, San Diego, CA). Cytosolic fractions
were collected by rocking cell monolayers on ice in a permeabilizing
buffer (in mM; KCl, 120; KH2PO4, 5; HEPES, 10; EGTA, 2; and
digitonin, 15mg/ml at pH 7.4) for 15 min. Digitonin selectively
permeabilizes the plasma membrane.21 The supernatant was
harvested as the ‘cytosolic’ cell fraction. Samples were sonicated,
spun at 10,000 g, and supernatants collected. Mitochondria were
harvested using a ‘Mitochondrial Isolation Kit for Mammalian Cells’
(Pierce, Rockford, IL) following the manufacturer’s protocol. The
degree of purification of each cell fraction was assessed using
standard markers.48 Protein levels were measured using the
bicinchoninic acid assay (Pierce) and equal amounts of protein
were separated on 7.5–12% tris-glycine polyacrylamide gels.
Separated proteins were transferred to nitrocellulose membranes
and antigens detected with primary antibodies and chemilumines-
cent reagents described below.
Immunoprecipitation
Immunoprecipitation was performed as recently described by our
laboratory.49 In brief, 7.5 106 cells were harvested in buffer
containing (in mM): NaCl, 150; Tris HCl, 10; EDTA, 5; EGTA, 1; 1%
Triton X-100, 0.5% NP-40, with protease inhibitors at pH 7.4.
Lysates were centrifuged at 10,000 g for 10 min at 41C. Samples
containing 200 mg total protein were incubated overnight at 41C
with 2 mg of antibody directed against total Bax (Cell Signaling,
Danvers, MA, cat #2772) and were then probed with antibodies
directed against total Bax or HK II (Cell Signaling).
Antibodies
Antibodies to HK II (C-14), VDAC, AIF, and total Bax (N-20) were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
active (6A7) Bax antibody was purchased from Trevigen (Gaithers-
burg, MD). Antibodies directed against phospho-ser9 GSK3b
(inactive), total GSK3b, pro-caspase 3, and an alternate HK
II–C64G5 antibody (used for immunohistochemistry) were obtained
from Cell Signaling. b-Actin was purchased from Sigma (St Louis,
MO), b-tubulin from ICN (Costa Mesa, CA) and mitochondrial-
specific F1F0-ATPase (complex V b-subunit) from Invitrogen.
Secondary antibodies conjugated to horseradish peroxidase (Jackson
Immunoresearch Laboratories, West Grove, PA) were used in
conjunction with chemiluminescent reagents from Boston BioProducts.
Cy3 and fluorescein isothiocyanate-conjugated secondary antibodies
were used to localize HK II in cells (Jackson; described below). Primary
antibodies in tissue were detected with AlexaFluor 488 and 594-
conjugated secondary antibodies (Invitrogen; described below).
Immunofluorescence
Cells were seeded on glass coverslips in 24-well plates for 24 h. After
stress, cells were washed in ice-cold 1 PBS, fixed in methanol for
30 min, and stored overnight in 75% ethanol at 41C. After washing
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three times in PBS, cells were permeabilized for 5 min in 0.2%
saponin, 0.03 mol/l sucrose, 1% bovine serum albumin (BSA) in
PBS, washed three more times for 5 min each in PBS, and blocked
for 30 min in 5% BSA in PBS. Cells were then incubated in anti-HK
II (1:50 dilution; 1% BSA in PBS) and anti-Cox IV antibodies (1:50
dilution; 1% BSA in PBS) overnight at 41C. After four washes in
PBS, cells were incubated in cy3-conjugated secondary antibody
(1:200; 1% BSA in PBS) for 1 h, washed three times in PBS, and
mounted onto glass slides with gelvatol. Slides were imaged by
confocal microscopy (Perkin Elmer Ultraview Scanning Disc
Microscope, Wellesley, MA).
Mitochondrial morphology was examined in live cells grown on
MatTek culture dishes (MatTek, Ashland, MA) and incubated with
Mitotracker green FM (100 nmol/l; Invitrogen) in standard culture
media for 1 h as previously described.17 Before visual inspection by
confocal microscopy, the MitoTracker was removed and the medium
was replaced.
Tissue. After intraperitoneal injection of tribromoethanol
(250 mg per kg body weight), the heart was exposed by bilateral
thoracic incision. A catheter was placed in the left ventricle and 10 ml
of 4% paraformaldehyde was infused at a rate of 6 ml/min. The kidney
was removed, cut into four pieces and placed in 4% paraformaldehyde
overnight. After washing twice in PBS, the kidney was placed in 15%
sucrose for 1 h, followed by 30% sucrose at 41C until the sample no
longer floated. The samples were then imbedded using Tissue-Tek
O.C.T. compound (Sakura Finelek, Torrance, CA) and cut into 5mm
sections using a cryostat.
For tissue staining, sections were washed three times for 5 min
each in PBS followed by 5 m in PBS containing 1% SDS. After three
additional washes, tissue sections were blocked for 1 h in PBS
containing 5% normal goat serum and 0.3% Triton X-100.
Following three washes, sections were incubated for 90 min with
antibodies against F1F0-ATPase (2 mg/ml) and HK II (1:400 dilution)
in PBS with 1% BSA and 0.3% Triton X-100. After three PBS washes,
sections were incubated in AlexaFluor 488- (1:250 dilution) and
AlexaFluor 594 (1:500 dilution)-conjugated secondary antibodies
(1% BSA, 0.3% Triton X-100 in PBS) for 1 h, washed three final
times in PBS, mounted with gelvatol, and examined by confocal
microscopy as described above. Slides were also imaged by phase
contrast and wide-field epifluorescence microscopy followed by
deconvolution using Image J software (National Institutes of Health,
Bethesda, MD).
Cell viability
Survival after ATP depletion was measured by MTT (Promega,
Madison, WI) assay, a technique based on the ability of cells
to convert 3-(4,5 dimethylthiazol)-2,5-diphenyl tetrazolium
bromide into purple formazan crystals that can be solubilized in
10% SDS, 0.01 N HCl. Samples (200 ml each) were loaded onto a
96-well plate and read at 595 nm on a plate reader. The number
of surviving cells is expressed as the percentage of viable control cells
at baseline.
HK II overexpression
Cells were incubated in DMEM containing 2% fetal bovine serum
and adenovirus containing a full-length human HK II construct
(50 moi for 6 h). The media was replaced with 10% fetal bovine
serum in DMEM and the cells were allowed to incubate overnight
before the experiments were performed. HK II overexpression was
confirmed by immunoblot analysis.
ATP content
A luciferase-based ATP kit (Invitrogen) was used to determine
cellular ATP levels before, during, and after stress. Following each
experiment, cells were washed twice with ice-cold PBS followed by
2.5% (w/v) trichloroacetic acid. Cells were then scraped from the
dish and centrifuged at 10,000 g for 5 min at 41C. The supernatant
was diluted 10 times and neutralized with tris acetate buffer (pH
7.75). ATP content was determined in triplicate in each sample
following the manufacturer’s protocol and was compared with a
freshly prepared standard curve derived from samples with known
ATP content.
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